InnovaRx Innova Health Strategies

N85.6

Intrauterine synechiae

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 13 never code together
N85code
Excludes1
  • endometriosis (N80.-)N80.-
  • inflammatory diseases of uterus (N71.-)N71.-
  • noninflammatory disorders of cervix, except malposition (N86-N88)N86-N88
  • polyp of corpus uteri (N84.0)N84.0
  • uterine prolapse (N81.-)N81.-
N00-N99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes

No further instructional notes apply.

Index entries leading here 6
  • Adhesions, adhesive (postinfective) K66.0
  • Syndrome — see also Disease
  • Asherman's syndrome N85.6
  • Band (s)
  • Synechia (anterior) (iris) (posterior) (pupil) — see also Adhesions, iris
    • intra-uterine (traumatic) N85.6
  • Stricture — see also Stenosis
    • uterus, uterine (synechiae) N85.6
Alongside this code 9 same parent — N85
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
N85
Block
N80-N98
Siblings
9

Present FY2024–FY2027.